Form 4 for AQST Aquestive Therapeutics, Inc.
Accepted 2025-09-08 00:00:00 ET · period of report 2025-09-04 · accession 0001214659-25-013493 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-09-08 | 2025-09-04 | AQST | Jung Cassie | COO | M - OptEx | $1.93 | +50.0K | 345.5K | +17% | +$96.5K |
| D | 2025-09-08 | 2025-09-04 | AQST | Jung Cassie | COO | S - Sale+OE | $5.00 | -62.2K | 283.3K | -18% | -$310.9K |
| DM | 2025-09-08 | 2025-09-04 | AQST | Jung Cassie | COO | M - OptEx | $0.00 | -50.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-04 | M | A | 25,000 | $3.15 | 320,526 | D | — | — | |
| 2 | Common | Common Stock | 2025-09-04 | S | D | 62,180 | $5.00 | 283,346 | D | — | — | |
| 3 | Common | Common Stock | 2025-09-04 | M | A | 25,000 | $0.71 | 345,526 | D | — | — | |
| 4 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-09-04 | M | D | 25,000 | $0.00 | 0 | D | $0.71 · — to 2032-08-05 | 25,000 Common Stock | (F4) This option was granted on August 5, 2022 and is fully vested. |
| 5 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-09-04 | M | D | 25,000 | $0.00 | 0 | D | $3.15 · — to 2029-08-09 | 25,000 Common Stock | (F3) This option was granted on August 9, 2019 and is fully vested. |